SuperworthaTYR PHARMA INC shares outstanding ATYR
Diluted shares outstanding, averaged over each quarter, from 2014.
- Latest quarter, to Jun 30, 2026
- 98.1M
- On a year earlier
- +8.8%
- more shares
aTYR PHARMA INC had 98.1M diluted shares outstanding on average in Q2 FY26, the quarter to Jun 30, 2026.
That is 8.8% more than a year earlier, so each share owns a little less of the company.
Shares outstanding over time
Fiscal year by fiscal year
| Fiscal year | Shares, fourth quarter | Change |
|---|---|---|
| FY2025 | 98M | +18% |
| FY2024 | 82.7M | +40% |
| FY2023 | 59.3M | +104% |
| FY2022 | 29.1M | +5% |
| FY2021 | 27.8M | +159% |
| FY2020 | 10.7M | +176% |
| FY2019 | 3.9M | +79% |
| FY2018 | 2.2M | +2% |
| FY2017 | 2.1M | +26% |
| FY2016 | 1.7M | +0% |
| FY2015 | 1.7M | +2631% |
| FY2014 | 61.7K | n/a |
Each fiscal year is the twelve months to its fourth quarter, shown as the fourth quarter's average share count.
Quarter by quarter
| Quarter | Ended | Shares outstanding | On a year earlier |
|---|---|---|---|
| Q2 FY26 | 98.1M | +9% | |
| Q1 FY26 | 98M | +13% | |
| Q4 FY25 | 98M | +18% | |
| Q3 FY25 | 97.2M | +28% | |
| Q2 FY25 | 90.1M | +25% | |
| Q1 FY25 | 86.5M | +31% | |
| Q4 FY24 | 82.7M | +40% | |
| Q3 FY24 | 75.8M | +31% | |
| Q2 FY24 | 72.3M | +31% | |
| Q1 FY24 | 66.1M | +58% | |
| Q4 FY23 | 59.3M | +104% | |
| Q3 FY23 | 57.9M | +102% |
What the shares outstanding tells you
Diluted shares outstanding, averaged over the period. Fewer shares means each one owns more of the company.
A falling count usually means buybacks. A rising one means stock pay, acquisitions paid in shares or new shares sold.
More on aTYR PHARMA INC
Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.